Humoral and cellular immune responses after three or four doses of BNT162b2 in patients with hematological malignancies.
Line Dam HeftdalSebastian Rask HammLaura Pérez-AlósJohannes Roth MadsenJose Juan Almagro ArmenterosKamille FoghChristoffer Cronwald KronborgAnders Pommer VallentinRasmus Bo HasselbalchDina Leth MøllerCecilie Bo HansenMia Pries-HejeAnne Ortved GangSisse Rye OstrowskiRuth Frikke-SchmidtErik SørensenLinda HilstedHenning BundgaardKasper IversenPeter GarredSusanne Dam NielsenKirsten GrønbaekPublished in: European journal of haematology (2023)
In conclusion, long-term humoral and cellular immune responses to BNT162b2 were impaired in patients with lymphoid malignancies.